+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Lymphocyte-mediated cytotoxicity against tumor cells II. Characteristics and tissue distribution of concanavalin A-activated cytotoxic effector cells



Lymphocyte-mediated cytotoxicity against tumor cells II. Characteristics and tissue distribution of concanavalin A-activated cytotoxic effector cells



European Journal of Immunology 6(5): 309-316



In vivo or in vitro activation of cytotoxic effector lymphocytes by concanavalin A (Con A) has been shown to result in a population of effector cells exhibiting a degree of immunological specificity when Con A was present during the cytotoxic assay (Waterfield, J.D. et al., Cell. Immunol. 1975. 17:392). In this communication we have characterized the Con A-activated effector cell by physical criteria and tried to assign it to a given subpopulation of thymus-derived lymphocytes. It was shown that macrophages played no role in target cell lysis in this system, nor was their presence required for Con A activation of the effector cell. The effector cell proved insensitive to anti-theta serum, but was classified as a T cell by the enrichment of cytotoxicity when a purified population of T cells was activated by Con A in vitro and by the failure to activate the effector cell in nude mice. Precursors of the effector cell were shown to reside primarily in the spleen, to be radioresistant up to 400 R, and to be short-lived after adult thymectomy. Thus, the effector cell can be classified with the T1 population of T cells and has similar characteristics as a cytolytically active cell described by Stobo et al. (J. Immunol. 1973. 110: 362, 652).

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040614005

Download citation: RISBibTeXText

PMID: 1086781

DOI: 10.1002/eji.1830060502


Related references

Lymphocyte-mediated cytotoxicity against tumor cells. III Differentiation of concanavalin A-activated cytotoxic effector cells. European Journal of Immunology 6(5): 317-320, 1976

Lymphocyte-mediated cytotoxicity against tumor cells specificity and characterization of concanavalin A-activated cytotoxic effector lymphocytes. Transplantation Reviews 29: 277-310, 1976

Lymphocyte-mediated cytotoxicity against tumor cells. I. Con A activated cytotoxic effector cells exhibit immunological specificity. Cellular Immunology 17(2): 392-404, 1975

Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes. Immunology 44(4): 685-693, 1981

Lymphocyte-mediated cytotoxicity against human allogeneic and autologous lymphoid targets after concanavalin A-activation of cytotoxic effector cells. Journal of Immunology 119(3): 1122-1128, 1977

Lymphocyte mediated cyto toxicity against tumor cells characterization of the concanavalin a activated cyto toxic effector cell. Scandinavian Journal of Immunology 4(7): 767-768, 1975

Lymphocyte mediated cyto toxicity against allogeneic tumor cells 4. fine specificity mapping and characterization of concanavalin a activated cyto toxic effector lymphocytes. Immunology 44(4): 685-694, 1981

Natural cell-mediated cytotoxicity against Trichomonas vaginalis in the mouse. I. Tissue, strain, age distribution, and some characteristics of the effector cells. Journal of Immunology 124(2): 508-514, 1980

Induction of lymphocyte-mediated cytotoxicity against allogeneic tumor cells by concanavalin A in vivo. Journal of Immunology 113(3): 870-875, 1974

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. Journal of Experimental Medicine 198(11): 1741-1752, 2003

Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. II. Sensitivity and specificity of the assays and characteristics of effector and sensitizing cells. Journal of the National Cancer Institute 58(2): 331-337, 1977

Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells. Journal of Experimental Medicine 140(2): 356-369, 1974

Lymphokine-activated killer and Bacillus Calmette-Guerin-activated killer cells Two ways of activation of cytotoxic effector cells against bladder tumor cells in vitro. European Journal of Cell Biology 63(Suppl. 40): 74, 1994

Spontaneous lymphocyte-mediated cytotoxicity and antibody-dependent cell cytotoxicity of human effector cells. Folia Haematologica 110(6): 831-842, 1983

Heterogeneity among human lymphocyte effector cells mediating spontaneous lymphocyte-mediated cytotoxicity. International Journal of Cancer 21(5): 594-603, 1978